Verdict. Here, we show that NGF and its precursor proNGF engage distinct cellular mechanisms. It intersects mitochondrial stress/dysfunction themes (reactive oxygen species).
What the authors report
Nerve growth factor (NGF) is a key mediator of pain through activation of the high-affinity tropomyosin receptor kinase A (TrkA) and the low-affinity neurotrophin receptor (p75NTR). Although neuronal TrkA signaling is well established, the contribution of non-neuronal cells to NGF- dependent pain remains unclear.
Key results stated in the abstract include the following. Here, we show that NGF and its precursor proNGF engage distinct cellular mechanisms. In Schwann cells, NGF and proNGF induced p75NTR-dependent calcium release, followed by TRPA1 activation, mitochondrial ROS production, and NOX1-dependent oxidative amplification. Inhibition of ROS or TRPA1, or Schwann cell-specific Trpa1 deletion, markedly reduced mechanical allodynia and cold hypersensitivity without affecting acute nociception or heat hyperalgesia.
Why it matters for mitochondrial biology
Within mitochondrial research, this work maps primarily to calcium signaling, redox biology, neurobiology, immunology. It is relevant to mitochondrial dysfunction discourse because the abstract invokes reactive oxygen species. That does not by itself establish a validated disease mechanism; it indicates thematic proximity. Because a therapeutic or interventional angle is present, the piece is of interest for mitochondrial-targeted drug hypothesis generation—subject to full-text validation of endpoints and safety context. Server: biorxiv. Posted 2026-08-17. Synthesis confidence is bounded by abstract completeness.
Study design (abstract-level)
The abstract does not cleanly separate methods from results. Treat design details as incomplete until the full preprint is inspected.
Principal findings
- Here, we show that NGF and its precursor proNGF engage distinct cellular mechanisms.
- In Schwann cells, NGF and proNGF induced p75NTR-dependent calcium release, followed by TRPA1 activation, mitochondrial ROS production, and NOX1-dependent oxidative amplification.
- Inhibition of ROS or TRPA1, or Schwann cell-specific Trpa1 deletion, markedly reduced mechanical allodynia and cold hypersensitivity without affecting acute nociception or heat hyperalgesia.
- These findings identify a Schwann cell p75NTR-ROS-TRPA1 pathway sustaining persistent pain and highlight non-neuronal p75NTR signaling as a potential therapeutic target.
Limitations of this brief
- This Mitos brief is an abstract-level synthesis of a preprint; it is not peer review and not a substitute for reading the full paper.
- Preprint status: findings may change with revision or journal review.
- Effect sizes, n numbers, statistics, and full experimental controls are typically incomplete at abstract resolution.
- Comparator/control language is weak or absent in the abstract, limiting causal inference from this brief alone.
- Primary source: biorxiv DOI 10.64898/2026.08.10.743924 (posted 2026-08-17).
Open scientific questions
- Which specific experimental panels in the full paper establish the strongest causal claim, and how robust are the controls?
- What dose, timing, and off-target profile would be required to take the intervention seriously as a therapeutic hypothesis?
- Is the mitochondrial phenotype cell-autonomous in neurons/glia, or secondary to systemic/inflammatory signals?
- How do these findings sit relative to prior literature on the same pathway—replication, contradiction, or incremental extension?
Bottom line
For mitochondrial biologists focused on calcium signaling, redox biology, neurobiology, this preprint is worth full-text review if the topic matches your program. Abstract-level takeaway: Here, we show that NGF and its precursor proNGF engage distinct cellular mechanisms. Confirm methods, effect sizes, and controls in the full PDF before citing the result as established.
Bibliographic record
| Field | Value |
|---|---|
| Title | Schwann cell p75NTR sustains persistent pain downstream to NGF through ROS-dependent TRPA1 signaling |
| DOI | 10.64898/2026.08.10.743924 |
| Server | biorxiv |
| Posted | 2026-08-17 |
| Topics | calcium signaling, redox biology, neurobiology, immunology, therapeutics |
| Mitos score | 67/100 |
| Confidence | medium |
| HTML | https://www.biorxiv.org/content/10.64898/2026.08.10.743924 |
| https://www.biorxiv.org/content/10.64898/2026.08.10.743924.full.pdf |
Abstract-based editorial synthesis by Mitos. Not peer review.
